Experience

Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by Applied Therapeutics, Inc. of shares of its common stock for up to a maximum offering…

Davis Polk advised the sole underwriter in connection with an SEC-registered secondary offering of 10,000,000 shares of common stock of BrightView Holdings, Inc. by KKR BrightView…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 5,980,000 shares of common stock of ChemoCentryx, Inc. (which…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coupa Software Incorporated of $1.38 billion aggregate principal amount of…

Davis Polk advised the initial purchasers on the Regulation S offering of high-yield notes by Ronshine China Holdings Limited of $250 million principal amount of 7.350% senior notes due…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1.75 billion aggregate principal amount of its 0.750% senior notes due 2023 and (ii) $1 billion…

Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $200 million 8.300% senior notes due 2023. Zhenro Properties Group…

Davis Polk advised Aptiv PLC in connection with a $1.1 billion SEC-registered offering of 15,149,519 ordinary shares (which included 1,976,024 ordinary shares that the underwriters…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Mohawk Capital Finance S.A. of fixed-rate notes due 2027. The notes are fully and unconditionally…

Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Westlake Chemical Corporation of $300 million aggregate principal amount of its 3.375%…